Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-06-07
2005-06-07
Tate, Christopher (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S325000
Reexamination Certificate
active
06903073
ABSTRACT:
The invention features a method of treating deficiency of insulin in a patient, comprising administering to a patient in need thereof hedgehog protein or nucleic acid in an amount effective to raise the level of insulin in the patient.
REFERENCES:
patent: 6127598 (2000-10-01), German et al.
patent: 6639051 (2003-10-01), Wang
patent: 2003/0083242 (2003-05-01), Galdes et al.
patent: 2003/0162698 (2003-08-01), Galdes et al.
patent: WO99/53038 (1999-10-01), None
Kim, et al., PNAS 1998, vol. 95 pp. 13036-13041. International Search Report.
Hebrok, et al., 1998 Genes and Dev. 12:1705.
Apelqvist, et al., 1997, Curr. Biol. 7:801.
Habener Joel F.
Thomas Melissa K.
Palmer & Dodge LLP
Tate Christopher
Teller Roy
The General Hospital Corporation
Williams Kathleen M.
LandOfFree
Methods to stimulate insulin production by pancreatic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods to stimulate insulin production by pancreatic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods to stimulate insulin production by pancreatic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3516068